Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Feb. 11, 1999

Biota's inhaled influenza drug recommended for approval in Australia

Feb. 10, 1999

Trovan I.V. potentially incompatible with normal saline and lactated Ringer's solutions

Feb. 10, 1999

New antibacterial series produced by Streptomyces discovered by Kyowa Hakko

Feb. 10, 1999

Status update for OPB-2045

Feb. 9, 1999

Oxazolidinones from P&U with broad-spectrum antibacterial activity

Feb. 9, 1999

New antiviral agents from SB for herpesvirus infections

Feb. 9, 1999

Novel semisynthetic macrolide antibiotics developed at Abbott

Feb. 5, 1999

Pediatric use of Maxipime approved by the FDA

Feb. 3, 1999

9a-Azalides with potent antibacterial activity in development at Merck

Feb. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...